Tizona Therapeutics
PrivateLast Round
Strategic
7/21/2020
Est. Valuation
$601.2M
Total Funding Raised
$448M
Company Overview
Tizona Therapeutics is an immunology company focused on developing treatments that leverage the immune system to achieve complete and lasting remissions for cancer and autoimmune diseases by modulating immunosuppressive cell activity in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tizona Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Tizona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | 7/21/2020 | ||||
| Strategic | 1/3/2019 | ||||
| Series B | 3/8/2016 |
Key People
Founding team and executive leadership
Tizona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series B |
| InterWest Partners | Series B |
| Lightstone Ventures | Series B |
| Amgen Ventures | Series B |
| Abingworth | Series B |
| Canaan Partners | Series B |
| Astellas Venture Management | Series B |
Tizona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tizona Therapeutics's valuation, stock price, and market status.
